Ticagrelor versus clopidogrel in real-world patients with ST elevation myocardial infarction: 1-year results by propensity score analysis

BACKGROUND: European guidelines recommend the use of ticagrelor versus clopidogrel in patients with ST elevation myocardial infarction (STEMI). This recommendation is based on inconclusive results and subanalyses from clinical trials. Few data are available on the effects of ticagrelor in a real-wor...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMC Cardiovasc Disord
Glavni autori: Vercellino, Matteo, Sànchez, Federico Ariel, Boasi, Valentina, Perri, Dino, Tacchi, Chiara, Secco, Gioel Gabrio, Cattunar, Stefano, Pistis, Gianfranco, Mascelli, Giovanni
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2017
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5382425/
https://ncbi.nlm.nih.gov/pubmed/28381298
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12872-017-0524-3
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items